Tag Archive for lupus

ImmuPharma’s chairman on realising the ‘blockbuster potential’ of firm’s lupus drug following major setback (IMM)

ImmuPharma (LSE:IMM) currently sits at 10.9p, having fallen from nearly 150p in April prior to reporting that its flagship Lupuzor™ drug had failed to meet the primary endpoint in its pivotal Phase III clinical trial. However, with the lupus drug largely missing its required ‘statistical significance’ due to an unusually high placebo response, ImmuPharma has…